Literature DB >> 33134977

Modulating microenvironments for treating glioblastoma.

LaDeidra Monet Roberts1, Jennifer Munson1.   

Abstract

PURPOSE OF REVIEW: This review focuses on the development and progression of glioblastoma through the brain and glioma microenvironment. Specifically we highlight how the tumor microenvironment contributes to the hallmarks of cancer in hopes of offering novel therapeutic options and tools to target this microenvironment. RECENT
FINDINGS: The hallmarks of cancer, which represent elements of cancers that contribute to the disease's malignancy, yet elements within the brain tumor microenvironment, such as other cellular types as well as biochemical and biophysical cues that can each uniquely affect tumor cells, have not been well-described in this context and serve as potential targets for modulation.
SUMMARY: Here, we highlight how the brain tumor microenvironment contributes to the progression and therapeutic response of tumor cells. Specifically, we examine these contributions through the lens of Hanahan & Weinberg's Hallmarks of Cancer in order to identify potential novel targets within the brain that may offer a means to treat brain cancers, including the deadliest brain cancer, glioblastoma.

Entities:  

Keywords:  Glioblastoma; brain microenvironment; cancer hallmarks; tumor microenvironment

Year:  2020        PMID: 33134977      PMCID: PMC7595245          DOI: 10.1007/s43152-020-00010-z

Source DB:  PubMed          Journal:  Curr Tissue Microenviron Rep        ISSN: 2662-4079


  112 in total

1.  High density is a property of slow-cycling and treatment-resistant human glioblastoma cells.

Authors:  Hanna Sabelström; David A Quigley; Trenten Fenster; Daniel J Foster; Clara A M Fuchshuber; Supna Saxena; Edith Yuan; Nan Li; Francesca Paterno; Joanna J Phillips; C David James; Börje Norling; Mitchel S Berger; Anders I Persson
Journal:  Exp Cell Res       Date:  2019-03-05       Impact factor: 3.905

2.  Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.

Authors:  Harald Krenzlin; Prajna Behera; Viola Lorenz; Carmela Passaro; Mykola Zdioruk; Michal O Nowicki; Korneel Grauwet; Hong Zhang; Magdalena Skubal; Hirotaka Ito; Rachel Zane; Michael Gutknecht; Marion B Griessl; Franz Ricklefs; Lai Ding; Sharon Peled; Arun Rooj; C David James; Charles S Cobbs; Charles H Cook; E Antonio Chiocca; Sean E Lawler
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

3.  Recapitulating in vivo-like plasticity of glioma cell invasion along blood vessels and in astrocyte-rich stroma.

Authors:  Pavlo Gritsenko; William Leenders; Peter Friedl
Journal:  Histochem Cell Biol       Date:  2017-08-19       Impact factor: 4.304

4.  Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.

Authors:  Alexander Birbrair; Anirudh Sattiraju; Dongqin Zhu; Gilberto Zulato; Izadora Batista; Van T Nguyen; Maria Laura Messi; Kiran Kumar Solingapuram Sai; Frank C Marini; Osvaldo Delbono; Akiva Mintz
Journal:  Stem Cells Transl Med       Date:  2016-09-14       Impact factor: 6.940

Review 5.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

Review 6.  Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.

Authors:  Kshama Gupta; Terry C Burns
Journal:  Front Oncol       Date:  2018-11-08       Impact factor: 6.244

7.  Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death.

Authors:  Simona Daniele; Chiara Giacomelli; Elisa Zappelli; Carlotta Granchi; Maria Letizia Trincavelli; Filippo Minutolo; Claudia Martini
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

8.  Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.

Authors:  J P Zepecki; K M Snyder; M M Moreno; E Fajardo; A Fiser; J Ness; A Sarkar; S A Toms; N Tapinos
Journal:  Oncogene       Date:  2018-10-23       Impact factor: 9.867

9.  Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.

Authors:  Jianbo Feng; Yan Zhang; Xiaoling She; Yingnan Sun; Li Fan; Xing Ren; Haijuan Fu; Changhong Liu; Peiyao Li; Chunhua Zhao; Qiang Liu; Qing Liu; Guiyuan Li; Minghua Wu
Journal:  Oncogene       Date:  2018-08-06       Impact factor: 9.867

10.  Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy.

Authors:  Rut Valdor; David García-Bernal; Dolores Riquelme; Carlos M Martinez; Jose M Moraleda; Ana Maria Cuervo; Fernando Macian; Salvador Martinez
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

View more
  2 in total

Review 1.  Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.

Authors:  Jennifer H Hammel; Jonathan M Zatorski; Sophie R Cook; Rebecca R Pompano; Jennifer M Munson
Journal:  Adv Drug Deliv Rev       Date:  2022-01-11       Impact factor: 15.470

2.  Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model.

Authors:  Emmanuela A Adjei-Sowah; Samantha A O'Connor; Jaimeson Veldhuizen; Costanza Lo Cascio; Christopher Plaisier; Shwetal Mehta; Mehdi Nikkhah
Journal:  Adv Sci (Weinh)       Date:  2022-05-26       Impact factor: 17.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.